A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults

Clinical trial NCT00798265 · TERMINATED

Trial details

NCT number: NCT00798265
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Human Immunodeficiency Virus Human Papillomavirus- 6, 11, 16, 18 Adolescent Papillomavirus Vaccines

Start date: 2009-06-29
Primary completion: 2012-09-22
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.